Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interferon-Gamma Modification of Mesenchymal Stem Cells: Implications of Autologous and Allogeneic Mesenchymal Stem Cell Therapy in Allotransplantation
Kisha N. Sivanathan, Stan Gronthos, Darling Rojas-Canales, et al.
Stem Cell Reviews and Reports (2014) Vol. 10, Iss. 3, pp. 351-375
Closed Access | Times Cited: 149

Showing 1-25 of 149 citing articles:

Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy
Xingliang Fan, Yuelin Zhang, Xin Li, et al.
Cellular and Molecular Life Sciences (2020) Vol. 77, Iss. 14, pp. 2771-2794
Open Access | Times Cited: 428
Mesenchymal Stem Cells: A Friend or Foe in Immune-Mediated Diseases
Marina Gazdic, Vladislav Volarević, Nebojša Arsenijević, et al.
Stem Cell Reviews and Reports (2015) Vol. 11, Iss. 2, pp. 280-287
Closed Access | Times Cited: 222
The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke
Catriona Cunningham, Elena Redondo‐Castro, Stuart M. Allan
Journal of Cerebral Blood Flow & Metabolism (2018) Vol. 38, Iss. 8, pp. 1276-1292
Open Access | Times Cited: 212
Engineering the MSC Secretome: A Hydrogel Focused Approach
Marissa E. Wechsler, Varsha V. Rao, Alexandra N. Borelli, et al.
Advanced Healthcare Materials (2021) Vol. 10, Iss. 7
Open Access | Times Cited: 115
Bioprocessing of Mesenchymal Stem Cells and Their Derivatives: Toward Cell-Free Therapeutics
Jolene Phelps, Amir Sanati‐Nezhad, Mark Ungrin, et al.
Stem Cells International (2018) Vol. 2018, pp. 1-23
Open Access | Times Cited: 149
Tissue engineering strategies for the induction of angiogenesis using biomaterials
Shirin Saberianpour, Morteza Heidarzadeh, Mohammad Hossein Geranmayeh, et al.
Journal of Biological Engineering (2018) Vol. 12, Iss. 1
Open Access | Times Cited: 126
Amniotic Membrane Mesenchymal Cells-Derived Factors Skew T Cell Polarization Toward Treg and Downregulate Th1 and Th17 Cells Subsets
Stefano Pianta, Patrizia Bonassi Signoroni, Ivan Muradore, et al.
Stem Cell Reviews and Reports (2014) Vol. 11, Iss. 3, pp. 394-407
Open Access | Times Cited: 125
The developmental basis of mesenchymal stem/stromal cells (MSCs)
Guojun Sheng
BMC Developmental Biology (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 120
Interleukin-17A-Induced Human Mesenchymal Stem Cells Are Superior Modulators of Immunological Function
Kisha N. Sivanathan, Darling Rojas-Canales, Christopher M. Hope, et al.
Stem Cells (2015) Vol. 33, Iss. 9, pp. 2850-2863
Open Access | Times Cited: 118
IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway
Ming Bai, Li Zhang, Bo Fu, et al.
Kidney International (2017) Vol. 93, Iss. 4, pp. 814-825
Open Access | Times Cited: 115
The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors
Matteo Bulati, Vitale Miceli, Alessia Gallo, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 82
Extracellular Vesicles from Interferon-γ–primed Human Umbilical Cord Mesenchymal Stromal Cells Reduce Escherichia coli–induced Acute Lung Injury in Rats
Amir K. Varkouhi, Mirjana Jerkić, Lindsay Ormesher, et al.
Anesthesiology (2019) Vol. 130, Iss. 5, pp. 778-790
Open Access | Times Cited: 81
Application of mesenchymal stem cell sheet for regeneration of craniomaxillofacial bone defects
Behnaz Banimohamad‐Shotorbani, Sonia Fathi‐karkan, Reza Rahbarghazi‬, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 31
Mesenchymal Stem Cells‐Involved Strategies for Rheumatoid Arthritis Therapy
Chaoyang Li, Yifu Sun, Weiguo Xu, et al.
Advanced Science (2024) Vol. 11, Iss. 24
Open Access | Times Cited: 15
Critical Role of Tumor Necrosis Factor Signaling in Mesenchymal Stem Cell-Based Therapy for Autoimmune and Inflammatory Diseases
Yan Li, Dejin Zheng, Ren‐He Xu
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 81
Small hypoxia-primed mesenchymal stem cells attenuate graft-versus-host disease
YongHwan Kim, Hye Jin Jin, Jinbeom Heo, et al.
Leukemia (2018) Vol. 32, Iss. 12, pp. 2672-2684
Open Access | Times Cited: 77
Update on Controls for Isolation and Quantification Methodology of Extracellular Vesicles Derived from Adipose Tissue Mesenchymal Stem Cells
Marcella Franquesa, Martin J. Hoogduijn, Èlia Ripoll, et al.
Frontiers in Immunology (2014) Vol. 5
Open Access | Times Cited: 76
A Clinical Indications Prediction Scale Based on TWIST1 for Human Mesenchymal Stem Cells
Siddaraju V. Boregowda, Veena Krishnappa, Christopher L. Haga, et al.
EBioMedicine (2015) Vol. 4, pp. 62-73
Open Access | Times Cited: 76
Hypoxia-cultured human adipose-derived mesenchymal stem cells are non-oncogenic and have enhanced viability, motility, and tropism to brain cancer
Yongzeng Feng, Mingxin Zhu, Sean Dangelmajer, et al.
Cell Death and Disease (2014) Vol. 5, Iss. 12, pp. e1567-e1567
Open Access | Times Cited: 73
Bottlenecks in the Efficient Use of Advanced Therapy Medicinal Products Based on Mesenchymal Stromal Cells
Natalia Escacena, Elena Quesada-Hernández, Vivian Capilla‐González, et al.
Stem Cells International (2015) Vol. 2015, pp. 1-12
Open Access | Times Cited: 68
Extrinsic and Intrinsic Mechanisms by Which Mesenchymal Stem Cells Suppress the Immune System
Vivien J. Coulson‐Thomas, Yvette M. Coulson‐Thomas, Tarsis F. Gesteira, et al.
The Ocular Surface (2016) Vol. 14, Iss. 2, pp. 121-134
Open Access | Times Cited: 67
Activated Mesenchymal Stromal Cells Process and Present Antigens Regulating Adaptive Immunity
Kayleigh M. van Megen, Ernst-Jan T. van ’t Wout, Julia Lages Motta, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 67
Safety Profile of Good Manufacturing Practice Manufactured Interferon γ-Primed Mesenchymal Stem/Stromal Cells for Clinical Trials
Adam J. Guess, Beth Daneault, Rongzhang Wang, et al.
Stem Cells Translational Medicine (2017) Vol. 6, Iss. 10, pp. 1868-1879
Open Access | Times Cited: 63
Mesenchymal stem cells immunomodulation: The road to IFN-γ licensing and the path ahead
Amandda Évelin Silva de Carvalho, Marielly Reis Resende Sousa, Thuany Alencar‐Silva, et al.
Cytokine & Growth Factor Reviews (2019) Vol. 47, pp. 32-42
Closed Access | Times Cited: 63
Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy
Jialin Meng, Xiaofan Lu, Yujie Zhou, et al.
Molecular Therapy — Oncolytics (2021) Vol. 20, pp. 410-421
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top